Company profile: Corimmun
1.1 - Company Overview
Company description
- Provider of novel therapeutics and diagnostics for heart and vascular diseases. A clinical drug development company based in Martinsried near Munich, Germany, Corimmun spans the full spectrum from research to drug development and commercialization.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corimmun
Crux Biomedical
HQ: United States
Website
- Description: Provider of biotech solutions addressing the clinical limitations of current vena cava filters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crux Biomedical company profile →
Huyabio
HQ: United States
Website
- Description: Provider of novel biopharmaceutical product opportunities, including HBI-8000, an oral class I selective HDAC inhibitor for cancers; HBI-3000, a multi-ion channel blocker for atrial fibrillation; HBI-2376, an SHP2 inhibitor for solid tumors; HBI-ONC, an epigenetic inhibitor for MDS/AML; and HBI-3800, a small molecule to regenerate cardiac muscle damaged by ischemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Huyabio company profile →
Endologix
HQ: United States
Website
- Description: Provider of minimally invasive treatments for aortic disorders, offering the AFX2 Endovascular AAA System for abdominal aortic aneurysms with specific aneurysm morphology; the ALTO Abdominal Stent Graft System for infrarenal abdominal aortic aneurysms requiring specific vascular morphology; and the DETOUR System for percutaneous revascularization of symptomatic femoropopliteal lesions in patients suboptimal for surgical or alternative endovascular treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endologix company profile →
Pronota
HQ: Belgium
Website
- Description: Provider of proprietary, non-invasive, validated diagnostics for early detection of life-threatening conditions and unmet medical needs, including heart failure, pre-eclampsia and sepsis, focused on improving quality of care for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pronota company profile →
Cleveland HeartLab
HQ: United States
Website
- Description: Provider of specialty clinical laboratory and disease management services focused on novel biomarker technologies and proprietary cardiovascular diagnostic tests, including inflammation testing, Cardio IQ lipid particle analysis, genetic and metabolic testing, and cardiovascular disease management, plus biomarker development R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cleveland HeartLab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corimmun
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corimmun
2.2 - Growth funds investing in similar companies to Corimmun
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corimmun
4.2 - Public trading comparable groups for Corimmun
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →